Home > Journals > Pediatric Education and Research

Pediatric Education and Research

Submit your article Read this Journals View all journals
Full Text (PDF)
Review Article

Contribution of Emile Roux in the Field of Pediatrics

Vaishnavi Bhagvan Suryawanshi, Kasumbiwal Ajay H, Lakhe Siddheshwar A, Pavani Kaithi

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Pediatric Education and Research 13(02 (Special Supplement)):p 305-308, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.70

How Cite This Article:

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Pavani Kaithi, et al. Contribution of Emile Roux in the Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 305-308.

Timeline

Received : December 17, 2025         Accepted : December 29, 2025          Published : December 31, 2025

Abstract

Emile Roux (1853–1933) was a pioneering French physician scientist whose work at the Pasteur Institute transformed the prevention and treatment of pediatric infectious diseases, particularly diphtheria. As a close collaborator of Louis Pasteur, he played a key role in the development of the rabies vaccine and later led the team that elucidated the role of diphtheria toxin and created diphtheria antitoxin serum. This serum therapy converted diphtheria from a dreaded pediatric killer into a treatable disease and dramatically reduced childhood mortality in Europe and beyond. Roux’s model of integrating meticulous laboratory research with carefully monitored clinical application in hospitals and orphanages helped establish bacteriology as a cornerstone of bedside pediatric care. His work laid the foundation for serum therapy, modern immunology, and vaccine-based prevention strategies. The legacy of Emile Roux continues to guide contemporary pediatric practice in infectious disease control, immunization policies, and evidence-based clinical decisionmaking. Key Messages: Emile Roux helped transform diphtheria from a leading cause of childhood death into a treatable disease through diphtheria antitoxin serum. His integration of laboratory bacteriology with clinical pediatrics laid the groundwork for modern pediatric infectious disease practice and vaccination policy.

References

No records found.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.

About this article

Cite this article

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Pavani Kaithi, et al. Contribution of Emile Roux in the Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 305-308.

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Received Accepted Published
December 17, 2025 December 29, 2025 December 31, 2025
DOI: 10.21088/per.2321.1644.13225.70

Keywords

Emile RouxDiphtheriaSerum TherapyPasteur InstitutePediatric Infectious Diseases

Article Level Metrics

Last Updated

Wednesday 17 June 2026, 14:56:36 (IST)

604

Accesses

1
108
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received December 17, 2025
Accepted December 29, 2025
Published December 31, 2025

licence

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share